We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App





Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond

By LabMedica International staff writers
Posted on 07 Aug 2019
Print article
Image: The cobas 8100 automated workflow series (Photo courtesy of Roche).
Image: The cobas 8100 automated workflow series (Photo courtesy of Roche).
Roche Diagnostics (Basel, Switzerland) launched its presence at the American Association for Clinical Chemistry (AACC) 2019 Clinical Lab Expo by showcasing how health networks are driving change in the lab and beyond. Roche showcased the latest solutions from its clinical lab portfolio, including chemistry, molecular and point-of-care diagnostics, automation and digital diagnostics. The company also provided a glimpse into its diagnostics products that are not yet available for sale in the U.S.

Roche continues to expand the Integrated Core Lab by consolidating and integrating a wider range of platforms across other disciplines that include molecular diagnostics and testing in coagulation, hematology and urinalysis. Roche solutions are also designed to address the lab's future needs, with pre-analytics and the next generation of automation that provides the ability to expand into liquid-based cytology and compatible analytics, all potentially connectable. The automation area included a fully automated configuration of an integrated core lab that consolidates routine chemistry and molecular testing.

Among the products highlighted by Roche at AACC 2019 was its cobas pro integrated solutions — an integrated mid-to-high volume solution for clinical chemistry and immunochemistry testing needs that is designed to achieve reduced maintenance and increased throughput through a scalable and modular system. The company showcased cobas prime — a pre-analytical system designed for standard processing and cross-contamination control of molecular samples — and cobas e 801 module — a high-volume immunoassay platform that provides nearly twice the throughput on the same footprint as its predecessor.

Roche also showcased cobas c 513 — a fully automated chemistry analyzer that raises the standard in HbA1c testing throughput — and the cobas 6800 system — a fully-automated, moderate-complexity platform that brings transformational efficiency gains to molecular diagnostics. The company also highlighted the cobas Connection Module (CCM) — a high-volume automation solution that provides connectivity across disciplines and third-party platforms — and the cobas Liat PCR system — a point-of-care analyzer with CLIA-waived, real-time PCR tests for flu A/B, flu A/B + RSV and strep A that provide lab-quality results in 20 minutes or less.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.